Label-Free Dynamic Mass Redistribution Assay To Characterize Holistic Chemokine Receptor Pharmacology in Neutrophils.
作者信息
Thomsen Alex R B
机构信息
Department of Molecular Pathobiology and NYU Pain Research Center, New York University College of Dentistry, New York, New York
出版信息
J Pharmacol Exp Ther. 2024 Mar 15;389(1):15-18. doi: 10.1124/jpet.123.001976.
Abstract
摘要
相似文献
1
Label-Free Dynamic Mass Redistribution Assay To Characterize Holistic Chemokine Receptor Pharmacology in Neutrophils.用于表征中性粒细胞中整体趋化因子受体药理学的无标记动态质量再分布分析
J Pharmacol Exp Ther. 2024 Mar 15;389(1):15-18. doi: 10.1124/jpet.123.001976.
2
Applying label-free dynamic mass redistribution assay for studying endogenous FPR1 receptor signalling in human neutrophils.应用无标记动态质量再分布分析研究人中性粒细胞内源性FPR1受体信号传导。
J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):72-78. doi: 10.1016/j.vascn.2017.07.003. Epub 2017 Jul 15.
3
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.神经肽 S 受体的药理学特征：动态质量重分布研究。
Pharmacol Res Perspect. 2018 Dec 3;6(6):e00445. doi: 10.1002/prp2.445. eCollection 2018 Dec.
4
The Neutrophil Dynamic Mass Redistribution Assay as a Medium throughput Primary Cell Screening Assay.中性粒细胞动态质量再分布检测作为一种中等通量的原代细胞筛选检测方法。
J Pharmacol Exp Ther. 2024 Mar 15;389(1):19-31. doi: 10.1124/jpet.123.001787.
5
Label-free cell-based dynamic mass redistribution assays.基于无标记细胞的动态质量再分布分析
Curr Protoc Chem Biol. 2014 Mar 14;6(1):39-51. doi: 10.1002/9780470559277.ch130205.
6
Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils.神经肽P物质上调原代小鼠中性粒细胞中趋化因子及其受体的表达。
Am J Physiol Cell Physiol. 2007 Aug;293(2):C696-704. doi: 10.1152/ajpcell.00060.2007. Epub 2007 May 9.
7
Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils.变构靶向法靶向作用于游离脂肪酸 2 型受体（GPR43）可恢复脱敏的人中性粒细胞的反应性。
J Leukoc Biol. 2021 Apr;109(4):741-751. doi: 10.1002/JLB.2A0720-432R. Epub 2020 Aug 17.
8
Live Imaging of Chemokine Receptors in Zebrafish Neutrophils During Wound Responses.斑马鱼中性粒细胞在创伤反应过程中趋化因子受体的实时成像。
J Vis Exp. 2020 Dec 4(166). doi: 10.3791/61679.
9
Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish.调控鱼类应激诱导中性粒细胞再分布的进化保守机制。
Front Immunol. 2024 Mar 7;15:1330995. doi: 10.3389/fimmu.2024.1330995. eCollection 2024.
10
Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.Toll样受体4（TLR4）信号传导通过调节趋化因子受体的细胞表面表达来增强趋化因子诱导的中性粒细胞迁移。
Nat Med. 2003 Mar;9(3):315-21. doi: 10.1038/nm832. Epub 2003 Feb 18.
本文引用的文献
1
The Neutrophil Dynamic Mass Redistribution Assay as a Medium throughput Primary Cell Screening Assay.中性粒细胞动态质量再分布检测作为一种中等通量的原代细胞筛选检测方法。
J Pharmacol Exp Ther. 2024 Mar 15;389(1):19-31. doi: 10.1124/jpet.123.001787.
2
Key aspects of modern GPCR drug discovery.现代 G 蛋白偶联受体药物发现的关键方面。
SLAS Discov. 2024 Jan;29(1):1-22. doi: 10.1016/j.slasd.2023.08.007. Epub 2023 Aug 23.
3
Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils.变构靶向法靶向作用于游离脂肪酸 2 型受体（GPR43）可恢复脱敏的人中性粒细胞的反应性。
J Leukoc Biol. 2021 Apr;109(4):741-751. doi: 10.1002/JLB.2A0720-432R. Epub 2020 Aug 17.
4
Neutrophil chemoattractant receptors in health and disease: double-edged swords.健康与疾病中的中性粒细胞趋化因子受体：双刃剑
Cell Mol Immunol. 2020 May;17(5):433-450. doi: 10.1038/s41423-020-0412-0. Epub 2020 Apr 1.
5
Neutrophils as emerging therapeutic targets.中性粒细胞：新兴的治疗靶点
Nat Rev Drug Discov. 2020 Apr;19(4):253-275. doi: 10.1038/s41573-019-0054-z. Epub 2020 Jan 22.
6
Neutrophil Diversity in Health and Disease.中性粒细胞的多样性在健康与疾病中的作用。
Trends Immunol. 2019 Jul;40(7):565-583. doi: 10.1016/j.it.2019.04.012. Epub 2019 May 31.
7
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons.原发性人基质细胞和 iPS 衍生神经元的无标记毒理学筛选
PLoS One. 2018 Sep 4;13(9):e0201671. doi: 10.1371/journal.pone.0201671. eCollection 2018.
8
Lack of beta-arrestin signaling in the absence of active G proteins.在缺乏活性G蛋白的情况下β-抑制蛋白信号缺失。
Nat Commun. 2018 Jan 23;9(1):341. doi: 10.1038/s41467-017-02661-3.
9
Applying label-free dynamic mass redistribution assay for studying endogenous FPR1 receptor signalling in human neutrophils.应用无标记动态质量再分布分析研究人中性粒细胞内源性FPR1受体信号传导。
J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):72-78. doi: 10.1016/j.vascn.2017.07.003. Epub 2017 Jul 15.
10
A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation.用于评估选择性、偏向性和受体突变的激动作用及变构调节量表
Mol Pharmacol. 2017 Oct;92(4):414-424. doi: 10.1124/mol.117.108787. Epub 2017 Jul 5.
Zotero 插件